Inactief instrument

Koers VERA PHARADR Nasdaq

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA	05-06-17
Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference	23-05-17
Verona Pharma Announces Closing of Exercise of Underwriters’ Over-allotment Option	18-05-17
Grant of Options and RSUs and PDMR Dealings	03-05-17
Verona Pharma Announces Closing of Global Offering	02-05-17

Sector